Nursing Lecturer receives national recognition for drug research
The University of Notre Dame, Sydney Campus
A lecturer from the School of Nursing at The University of Notre Dame Australia, Sydney has received national recognition for his study into reducing adverse events associated with the blood thinning drug, Warfarin.
Mr Jed Duff received two national awards for his Warfarin Anticoagulation Safety Project; The Australian Private Hospitals Association (AHPH) Baxter Award for Clinical Excellence and the Australian Council on Healthcare Standards Quality Improvement Award (ACHS).
“It is a privilege to receive these two awards and to have the project’s success acknowledged by my peers,” said Mr Duff.
The ACHS awards are held annually and aim to identify the achievement of a member who has developed innovative systems that improve health care quality and safety. The AHPH Awards recognise private hospitals and individuals who have made an outstanding contribution to patient treatment and care.
The Warfarin project was the final part of Mr Duff’s Masters in Nursing (Clinical Leadership) course and was run over 12 months at St Vincent’s Private Hospital. Its aim was to improve clinician compliance with the evidence based guidelines on Warfarin management.
“Warfarin is one of the most widely prescribed drugs in Australia; unfortunately, it is also a difficult drug to use. We used evidence-based guidelines to help reduce the risks associated with this essential yet complex therapy,” said Mr Duff.
Moira Saunders 02 8204 4407
Saunders, Moira, "Nursing Lecturer receives national recognition for drug research" (2008). Media Release Archive. 477.